Table: Torii Pharmaceutical -2016 parent results
Feb 2 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Dec 31, 2015 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 60.21 62.38 64.50
(-3.5 pct) (+7.1 pct)
Operating 3.82 4.92 5.30
(-22.4 pct) (+38.8 pct)
Recurring 4.00 5.14 5.40
(-22.1 pct) (+35.0 pct)
Net 2.84 3.53 3.90
(-19.5 pct) (+37.3 pct)
EPS 100.41 yen 124.65 yen 139.04 yen
Ann Div 48.00 yen 48.00 yen 48.00 yen
-Q2 Div 24.00 yen 24.00 yen 24.00 yen
-Q4 Div 24.00 yen 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)